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Abstract 
Mullerian tumors are extremely rare malig-
nancies in the retroperitoneum. We report a
case of a 46-year old woman who presented
with an eight year history of lower abdominal
mass.  Ultrasonography  (US)  and  computed
tomography  (CT)  demonstrated  a  15×10  cm
cystic mass in the left lower retroperitoneum.
As serial percutaneous needle aspiration cytol-
ogy  was  negative  for  malignancy,  she  was
observed for seven years. Eleven months ago,
the mass was excised. The histopathology was
reported as mucinous adenocarcinoma of the
retroperitoneum. Six cycles of intraperitoneal
(IP)  chemotherapy  was  administered  during
the last six months after diagnosis of recur-
rence by aspiration cytology and high serum
tumor markers (CEA, CA19-9). A few days ago,
positron  emission  tomographic  (PET)  scan-
ning showed evidence of local recurrence and
single vertebral metastasis, so she was admit-
ted  again  for  systemic  chemotherapy.
Meticulous revision of additional sections of
the  tumor  revealed  papillary,  serous,  muci-
nous, and endometrioid subtypes of the mul-
lerian  adenocarcinoma.  To  our  knowledge,
there has been no similar case described in
the literature.
Introduction 
Malignant mullerian tumors usually arise in
the uterine corpus,
1 but cases in other sites of
the  genital  tract,  such  as  vagina,
2 uterine
cervix,
3 fallopian tube,
4 and ovary,
5 have occa-
sionally been reported. Extragenital malignant
mullerian  tumors  arising  from  the  peri-
toneum, the pelvic wall, or omentum have been
documented.
6-9 Among  the  extragenital  sites,
the retroperitoneum is one of the rarest sites,
and,  to  the  best  of  our  knowledge,  primary
retroperitoneal  adenocarcinoma  of  mullerian
origin  has  been  documented  in  only  3  case
reports.
10-12 We  report  here  the  first  case  of
retroperitoneal  primary  mullerian  cystadeno-
carcinoma  with  serous  papillary,  mucinous,
and endometrioid components.
Case Report
A  premenopausal  46-year  old  woman  had
noticed a painless slowly enlarging mass in
the left lower abdomen eight years ago. There
was no history of endometriosis, pelvic irradi-
ation, or exogenous estrogen administration.
Physical examination revealed a slightly ten-
der, ill-defined mass about 15 cm in size over
the left lower abdomen. The remaining sys-
temic examination did not reveal any coexis-
tent  lesions.  The  laboratory  tests,  including
the complete blood count, the chemistry pro-
file, urinalysis and chest X-ray, were all within
normal  limits.  Abdominopelvic  computed
tomography  (CT)  scanning  revealed  a  large
unilocular  cystic  mass  with  an  enhancing
solid portion, and this was probably located in
the retroperitoneal space (Figure 1A). There
was no evidence of extracystic extension or
distant metastasis. Serial percutaneous aspi-
ration cytology was negative for malignancy.
Eleven months ago, the patient was referred to
our  center  where  a  repeat  CT  scanning
demonstrated cystic mass of the same previ-
ous size with a thick wall and homogenous
fluid content. Percutaneous aspiration by 14G
needle yielded brownish red thick fluid, but
the cytology was also negative for malignancy.
Laparotomy revealed a grossly normal uterus,
2 ovaries, 2 fallopian tubes and an appendix.
There were no abnormal findings in the liver,
stomach, small bowel, large bowel and spleen.
A large, encapsulated cystic mass about 15 cm
in diameter was found in the left retroperi-
toneum. It was not connected to the bowels or
other organs. The descending colon was dis-
placed medially to the mass, and no ascites
was found. Excision of the cystic mass with a
part of the left fallopian tube was carried out.
However, the capsule was ruptured accidental-
ly  during  resection  releasing  necrotic  and
brown mucoid viscous material. Hysterectomy,
salpingoophorectomy, appendectomy and lym-
phadenectomy  were  not  performed.  The
serum  tumor  markers  were  not  checked
before tumor excision. 
The gross pathological findings showed a
15×12 cm sized, unilocular cystic mass cov-
ered by a thick fibrous capsule and focally by
peritoneum.  The  inner  surface  of  the  cyst
showed  cobble  stone  appearance  with  three
solid mural nodules that were 1.5, 1 and 2 cm
in  diameter,  respectively.  The  cystic  wall
measured 0.7 cm at the maximum thickness.
There was evidence of capsular rupture. The
mural nodules were soft and yellowish (Figure
1B and C). Microscopically, as the cyst was
lined by atypical columnar cells of mucinous
type, the diagnosis was mucinous cystadeno-
carcinoma. Two months later, a peritoneal port
system  was  introduced  into  the  abdominal
cavity for administration of IP chemotherapy.
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After  the  patient  was  subsequently  treated
with 3 cycles of IP cisplatin and docetaxel (40
mg each) in 500 mL physiological saline, the
aspiration cytology was negative for malignan-
cy, but after a further two months, it showed
class-V adenocarcinoma. A repeat CT did not
show relevant data (Figure 2A) but PET scan-
ning revealed an area of 8×7 cm with high
standard uptake value (SUV) of 18F-FDG in
the left iliac fossa, and in the 12th thoracic
vertebral body, and some accumulation of 18F-
FDG in the pelvis, paracolic gutters and peri-
toneum (Figure 2B and C). The serum CEA
increased to 6.8 ng/mL, CA 19-9 was 465 U/mL
(normal range: <37), and the CA125 was 19.9
U/mL (normal range: <35). 
Meticulous revision of additional sections,
however, revealed mixed adenocarcinomatous
components containing many subtypes; papil-
lae  and  tubules  of  serous  adenocarcinomas
subtype that have complex branching papillae
with prominent epithelial stratification yield-
ing epithelial tufts and an apparently detached
epithelial  cell  cluster  (Figure  3A  and  B).
Mucinous  adenocarcinoma  subtype  is  com-
posed of cells similar to those present in ade-
nocarcinomas  of  the  large  intestine  with
many goblet cells. There is also pseudostratifi-
cation, and only small amounts of intracellular
mucin present (Figure 3C and D). Scattered
areas  of  endometrioid  adenocarcinoma  sub-
type was also evident with the characteristic
histology of tubular glands. The cells tend to
be stratified and have oval nuclei that were
arranged with their long axis perpendicular to
the  basement  membrane  of  the  gland.  The
cells do not contain mucin and have less cyto-
plasm (Figure 3E and F). The predominant cell
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[page 16] [Rare Tumors 2010; 2:e6]type  was  mucinous  adenocarcinoma.  Each
component of the other cell type was about
15%. In carcinoma cells, immunohistochemi-
cal staining was strongly positive for cytoker-
atin 7 (monoclonal, DAKO, 1:50) but was neg-
ative for CK20 (monoclonal, DAKO, 1:50). The
stromal cells which were focally found in the
cyst wall were positive for CD10 (monoclonal,
DAKO, 1:50) (Figure 3G and H). However, no
immunoreactivity was found to estrogen and
progesterone receptors (ER/PR). 
The excised segment of the left fallopian
tube was associated with a surrounding dense
fibrosis  but  the  tube  itself  did  not  show
mucosal abnormalities. There was no lymph
vascular invasion and the peritoneal biopsies
were negative for metastasis. The patient is
currently receiving repeat chemotherapy with
6 courses of cisplatin and docetaxel.
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Figure 2. (A) CT scan failed to show relevant data. (B) A 18-FDG PET scintigraphy. There
is intense focal area of 18-FDG activity in the left iliac fossa which corresponds to the
same  slice  of  CT  scan.  This  is  consistent  with  recurrent  disease  (peritoneal  surface
implant). The right paracolic gutter adjacent to the cecum in the right iliac fossa has
hypermetabolic activity. (C) Increased tracer activity is in the vertebral body of the last
thoracic vertebra, which may represent metastatic deposit.
Figure 3. Histological
findings  of  the
retroperitoneal tumor,
(A,  B)  showing
branching  papillae
and  apparently
detached  epithelial
cell  clusters.  Atypical
epithelial  cells  with
pleomorphic  nuclei
and  frequent  mitotic
figures  can  be  seen.
(H&E,  ×40,  ×100).
(C,  D)  showing  the
columnar  cells  of
mucinous  adenocarci-
noma  portion  with
many goblet cells and
pseudostratification.
(H&E, ×40, ×100). (E,
F) showing the charac-
teristic tubular glands
of  the  endometrioid
subtype.  The  cells
have  tendency  for
stratification,  and
having  oval  nuclei
(H&E,  ×40,  ×100).
(G)  A  positive  result
for  CK7  staining  in
the  adenocarcinoma
cells (×100). (F) stro-
mal  cells  show
immunoreactivity  to
CD10 (×100).
Figure 1. (A) Contrast-enhanced abdomi-
no-pelvic CT scan shows a large unilocular
cystic mass in the left retroperitoneal space.
There is an enhancing solid portion in the
posterolateral  side  of  the  cyst.  (B,  C)
Photograph  of  cut  specimens  of  the  cyst
shows cobble stone appearance with mural
nodules. The resected part of left fallopian
tube is shown (arrows). 
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Although extragenital malignant mullerian
tumors occur infrequently, their clinical fea-
ture and diverse spectrum of histopathologi-
cal  pattern  has  been  a  subject  of  interest.
Approximately half the cases reported in the
literature  are  located  in  the  pelvic  peri-
toneum,  followed  in  decreasing  frequency
from the serosal surface of colon, retroperi-
toneum, anterolateral abdominal peritoneum
and omentum.
7-9 Our case of mullerian adeno-
carcinoma appears to have originated in the
retroperitoneum in view of its location and
gross  appearance.  Although  a  part  of  this
tumor  was  attached  to  the  peritoneum  and
had ruptured into the pelvic cavity, an origin
in  the  peritoneal  surface  can  be  excluded,
judging from the clinical history and findings
at surgical exploration. 
Most  extragenital  malignant  mullerian
tumors  occur  in  elderly  postmenopausal
women.  The  relation  between  their  occur-
rence and previous irradiation or chemother-
apy for other gynecological malignancies has
been reported in the literature.
7,14 We believe
this  case  to  be  of  importance  because  the
patient in this report was a premenopausal
woman who had neither carcinomas in the
genital tract nor had a history of irradiation
or chemotherapy. However, its occurrence in
the reproductive age may suggest a possible
hormonal influence on the etiology.
One of the features of female genital carci-
nomas is the presence of steroid receptors in
tumor  cells,  including  ER/PR.  In  our  case,
immunohistochemical  studies  showed  the
tumor cells were negative for ER/PR suggest-
ing  that  they  are  hormone-independent
tumors.
Mullerian-type  neoplasms  have  been
reported infrequently in the retroperitoneum,
including  benign  mullerian  cyst,  mucinous
cystadenoma, carcinoma arising in mullerian
cyst,  serous  and  mucinous(cyst)adenocarci-
nomas, clear cell carcinoma, and endometrial
stromal  sarcoma.
12,15-19 The  present  case
showed uniphasic tumor that consisted of an
admixture  of  malignant  epithelial  compo-
nents. These epithelial components represent
a  variety  of  different  histological  subtypes;
papillary, serous, mucinous, and endometri-
oid features. To the best of our knowledge,
this  is  the  first  reported  case  of  primary
retroperitoneal mullerian tumor having these
mixed  subtypes  of  adenocarcinoma.
Interestingly, Shinmura et al.
10 documented,
incidentally at autopsy, a clear cell adenocar-
cinoma of the remnant uterus in persistent
mullerian duct syndrome in a man who died
in a traffic accident, and suggested remnant
of the mullerian duct in the retroperitoneum
as a possible origin of the tumor. The histoge-
nesis of extragenital neoplasms of mullerian-
type remains largely speculative. Two major
hypotheses  have  been  proposed.  The  first
hypothesis  assumes  the  presence  of
endometriosis as a possible origin of these
neoplasms.
6 Although this possibility is diffi-
cult to rule out, supporting evidence has been
found in only a small number of cases.
6,15 In
most  reported  cases  of  extragenital  muller-
ian-type tumors, and also in this case, coexis-
tence  of  endometriosis  with  the  tumor  has
not been demonstrated. The second hypothe-
sis  is  based  on  the  existence  of  the  “sec-
ondary mullerian system”, which was exten-
sively discussed by Lauchlan.
20 According to
this hypothesis, the coelomic epithelium cov-
ering the female peritoneal surface has the
potential  for  mullerian  differentiation,  a
potential  shared  by  the  underlying  “sub-
coelomic  mesenchyme”,  which  may  be  the
origin of the extragenital mullerian-type neo-
plasms arising in the retroperitoneum.
10,21
The present tumor was difficult to diagnose
not only because it is a rare condition in the
retroperitoneum but also due to microscopic
findings of many subtypes of adenocarcino-
ma. To identify the primary malignancy of the
tumor,  we  performed  immunohistochemical
analysis to achieve a differential diagnosis.
The positive CK7, the negative CK20, and the
presence of CD10 positive stromal cells in the
present case provided immunohistochemical
evidence suggesting a mullerian origin. 
The  early  tumor  recurrence  we  experi-
enced in this case may reflect the aggressive
nature  of  the  tumor  with  tendency  toward
local spread, and hematogenous metastases,
or the intraperitoneal seeding duo tumor rup-
ture that occurred accidentally at the time of
surgery.  It  is,  therefore,  essential  to  avoid
tumor rupture during the operation because
malignant cells may exist in the spilled fluid;
this results in subsequent peritoneal tumor
implantation. We recommend PET as a useful
diagnostic tool in defining the recurrence of
disease,  in  identifying  metastases,  and
assessing treatment effectiveness.
Primary retroperitoneal adenocarcinoma is
a rare tumor and in all reported cases, the
duration of follow-up was not more than five
years.
5 Due to the rarity of this tumor, no evi-
dence  based  management  guidelines  are
available.  Laparotomy  and  complete  tumor
excision should be the principal modality of
treatment.  Pathological  examination  is
inevitable to make a correct diagnosis. As the
role of adjuvant chemotherapy and/or radio-
therapy  is  not  well-defined,  patients  with
metastatic disease can be treated with pallia-
tive  chemotherapy.  Long-term  follow-up  is
essential to evaluate the course and progno-
sis of this disease.
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